Hepatitis C News and Research

Latest Hepatitis C News and Research

Vertex to conduct two Phase 2 studies of VX-135 in combination with daclatasvir

Vertex Pharmaceuticals Incorporated today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb Company to conduct Phase 2 studies of once-daily all-oral treatment regimens containing Vertex's nucleotide analogue hepatitis C virus polymerase inhibitor VX-135 and Bristol-Myers Squibb's NS5A replication complex inhibitor daclatasvir for the treatment of hepatitis C.

6 Apr 2013

State Highlights: St. Jude lawsuits could change medical-device liability protection; Calif. weighs charity minimum for nonprofit hospitals

A raft of lawsuits filed Thursday against St. Jude Medical Inc. over an implanted heart device could challenge the broad liability protection that medical-device makers have enjoyed since a key Supreme Court ruling in 2008.

6 Apr 2013

Research: Hepatitis A virus steals membranes from infected cells to protect it from antibodies

Viruses have historically been classified into one of two types - those with an outer lipid-containing envelope and those without an envelope.

5 Apr 2013

First Edition: April 5, 2013

Today's headlines include reports about how President Barack Obama's budget proposal -- to be released next week -- will handle Medicare and Medicaid.

5 Apr 2013

Anti-vaccination messages spread more easily than positive ones on Twitter, researchers find

On Twitter, a popular microblogging and social-networking service, statements about vaccines may have unexpected effects -- positive messages may backfire, according to a team of Penn State University researchers led by Marcel Salath-, an assistant professor of biology.

5 Apr 2013

Injuries caused by sharp instruments are major occupational hazard for surgeons

Injuries caused by needles and other sharp instruments are a major occupational hazard for surgeons—with high costs related to the risk of contracting serious infectious diseases, according to a special article in the April issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

3 Apr 2013

Inovio Pharmaceuticals reports release of phase II clinical trial results of ChronVac-C

Inovio Pharmaceuticals, Inc. today announced the release of preliminary clinical trial results by its collaborator ChronTech AS of their open label phase II clinical study of ChronVac-C, ChronTech's vaccine to treat hepatitis C virus infection.

2 Apr 2013

Eight new grant recipients to receive funding to conduct health impact assessments

The Health Impact Project, a collaboration of the Robert Wood Johnson Foundation and The Pew Charitable Trusts, today announced eight new grant recipients that will receive funding to conduct health impact assessments, or HIAs.

2 Apr 2013

Recent findings reveal correlations between autism prevalence, childhood vaccination

Recent finds in two articles in the Journal of Toxicology and Environmental Health, Part A indicate correlations between autism and vaccinations.

30 Mar 2013

Oklahoma dentist called 'menace to the public health'

Dr. W. Scott Harrington faces an April 19 hearing over unsanitary conditions that may have exposed patients to hepatitis B, hepatitis C and HIV infection.

30 Mar 2013

Medivir seeks FDA approval for simeprevir

Medivir AB today announced that a new drug application has been filed with the U.S. Food and Drug Administration seeking approval for simeprevir.

30 Mar 2013

Correctional policies discourage released inmates from seeking methadone therapy, researchers say

Methadone treatment for opioid dependence remains widely unavailable behind bars in the United States, and many inmates are forced to discontinue this evidence-based therapy, which lessens painful withdrawal symptoms.

30 Mar 2013

First Edition: March 29, 2013

Today's early morning highlights from the major news organizations, including coverage of renewed interest between President Barack Obama and congressional Republicans to find ways to cut Medicare costs:

29 Mar 2013

Stronger protections needed to prevent hepatitis in HIV patients

Stronger protections are needed to prevent people with HIV from also becoming infected with hepatitis, researchers argue in a new study led by Michigan State University.

28 Mar 2013

Indonesia to issue compulsory licenses for HIV, hepatitis B drugs still under patent

"The Indonesian government hopes to implement one of the largest ever examples of 'compulsory licensing,' which will enable the generic manufacture of drugs still under patent," IRIN reports.

27 Mar 2013

Researchers test protease inhibitors with potential for prevention, treatment of norovirus infection

A Kansas State University-led team is researching ways to stop the spread of norovirus, a contagious stomach illness that infects one in 15 Americans each year, according to the Centers for Disease Control and Prevention.

25 Mar 2013

HIV home tests: an interview with Dr Nitika Pant Pai, McGill University

30 years into the HIV epidemic, there is no vaccine in sight. Yet, even though there are fantastic and effective cheap and universally available drugs, and a treatment as prevention strategy is known to work, people do not wish to get tested for HIV! If everyone got tested, and treated, we could have brought the infection under control a long time ago!

21 Mar 2013

Hepatitis C and HIV co-infection treatment: an interview with Prof Boecher, Boehringer Ingelheim

Chronic hepatitis C infection is one of the most frequent chronic infectious diseases worldwide. The WHO estimates that 150 million people worldwide are chronically infected with the hepatitis C virus (HCV).

20 Mar 2013

Prevalence of acute hepatitis C virus infection is nearly 1% among newly incarcerated inmates

study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is nearly one percent among newly incarcerated inmates with a history of recent drug use.

20 Mar 2013

HCV screening of IV drug users new to the prison system could identify thousands of new HCV cases annually

A study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is nearly one percent among newly incarcerated inmates with a history of recent drug use. Findings suggest that systematic screening of intravenous (IV) drug users who are new to the prison system could identify more than 7,000 cases of HCV across the U.S. annually—even among asymptomatic inmates.

19 Mar 2013

Hepatitis C News and Research

Latest Hepatitis C News and Research

Vertex to conduct two Phase 2 studies of VX-135 in combination with daclatasvir

State Highlights: St. Jude lawsuits could change medical-device liability protection; Calif. weighs charity minimum for nonprofit hospitals

Research: Hepatitis A virus steals membranes from infected cells to protect it from antibodies

First Edition: April 5, 2013

Anti-vaccination messages spread more easily than positive ones on Twitter, researchers find

Injuries caused by sharp instruments are major occupational hazard for surgeons

Inovio Pharmaceuticals reports release of phase II clinical trial results of ChronVac-C

Eight new grant recipients to receive funding to conduct health impact assessments

Recent findings reveal correlations between autism prevalence, childhood vaccination

Oklahoma dentist called 'menace to the public health'

Medivir seeks FDA approval for simeprevir

Correctional policies discourage released inmates from seeking methadone therapy, researchers say

First Edition: March 29, 2013

Stronger protections needed to prevent hepatitis in HIV patients

Indonesia to issue compulsory licenses for HIV, hepatitis B drugs still under patent

Researchers test protease inhibitors with potential for prevention, treatment of norovirus infection

HIV home tests: an interview with Dr Nitika Pant Pai, McGill University

Hepatitis C and HIV co-infection treatment: an interview with Prof Boecher, Boehringer Ingelheim

Prevalence of acute hepatitis C virus infection is nearly 1% among newly incarcerated inmates

HCV screening of IV drug users new to the prison system could identify thousands of new HCV cases annually

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Hepatitis C News and Research

Latest Hepatitis C News and Research

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Newsletters you may be interested in